Table of Content

1 Study Coverage
1.1 Non-opioid Pain Med Product Introduction
1.2 Global Non-opioid Pain Med Outlook 2018 VS 2024 VS 2034
1.2.1 Global Non-opioid Pain Med Sales in US$ Million for the Year 2018-2034
1.2.2 Global Non-opioid Pain Med Sales in Volume for the Year 2018-2034
1.3 United States Non-opioid Pain Med Outlook 2018 VS 2024 VS 2034
1.3.1 United States Non-opioid Pain Med Sales in US$ Million for the Year 2018-2034
1.3.2 United States Non-opioid Pain Med Sales in Volume for the Year 2018-2034
1.4 Non-opioid Pain Med Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Non-opioid Pain Med in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Non-opioid Pain Med Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Non-opioid Pain Med Market Dynamics
1.5.1 Non-opioid Pain Med Industry Trends
1.5.2 Non-opioid Pain Med Market Drivers
1.5.3 Non-opioid Pain Med Market Challenges
1.5.4 Non-opioid Pain Med Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Non-opioid Pain Med by Type
2.1 Non-opioid Pain Med Market Segment by Type
2.1.1 Diclofenac Sodium
2.1.2 Acetaminophen
2.1.3 Indomethacin
2.1.4 Ibuprofen
2.1.5 Aspirin
2.1.6 Others
2.2 Global Non-opioid Pain Med Market Size by Type
2.2.1 Global Non-opioid Pain Med Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Non-opioid Pain Med Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Non-opioid Pain Med Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Non-opioid Pain Med Market Size by Type
2.3.1 United States Non-opioid Pain Med Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Non-opioid Pain Med Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Non-opioid Pain Med Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Non-opioid Pain Med by Application
3.1 Non-opioid Pain Med Market Segment by Application
3.1.1 Mild Pain
3.1.2 Moderate Pain
3.2 Global Non-opioid Pain Med Market Size by Application
3.2.1 Global Non-opioid Pain Med Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Non-opioid Pain Med Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Non-opioid Pain Med Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Non-opioid Pain Med Market Size by Application
3.3.1 United States Non-opioid Pain Med Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Non-opioid Pain Med Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Non-opioid Pain Med Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Non-opioid Pain Med Competitor Landscape by Company
4.1 Global Non-opioid Pain Med Market Size by Company
4.1.1 Global Key Manufacturers of Non-opioid Pain Med, Ranked by Revenue (2024)
4.1.2 Global Non-opioid Pain Med Revenue by Manufacturer (2018-2023)
4.1.3 Global Non-opioid Pain Med Sales by Manufacturer (2018-2023)
4.1.4 Global Non-opioid Pain Med Price by Manufacturer (2018-2023)
4.2 Global Non-opioid Pain Med Concentration Ratio (CR)
4.2.1 Non-opioid Pain Med Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Non-opioid Pain Med in 2024
4.2.3 Global Non-opioid Pain Med Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Non-opioid Pain Med, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Non-opioid Pain Med, Product Offered and Application
4.5 Global Key Manufacturers of Non-opioid Pain Med, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Non-opioid Pain Med Market Size by Company
4.7.1 Key Players of Non-opioid Pain Med in United States, Ranked by Revenue (2024)
4.7.2 United States Non-opioid Pain Med Revenue by Players (2018-2023)
4.7.3 United States Non-opioid Pain Med Sales by Players (2018-2023)
5 Global Non-opioid Pain Med Market Size by Region
5.1 Global Non-opioid Pain Med Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Non-opioid Pain Med Market Size in Volume by Region (2018-2034)
5.2.1 Global Non-opioid Pain Med Sales in Volume by Region: 2018-2023
5.2.2 Global Non-opioid Pain Med Sales in Volume Forecast by Region (2024-2034)
5.3 Global Non-opioid Pain Med Market Size in Value by Region (2018-2034)
5.3.1 Global Non-opioid Pain Med Sales in Value by Region: 2018-2023
5.3.2 Global Non-opioid Pain Med Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Non-opioid Pain Med Market Size YoY Growth 2018-2034
6.2 Americas Non-opioid Pain Med Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Non-opioid Pain Med Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Non-opioid Pain Med Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Non-opioid Pain Med Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Non-opioid Pain Med Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Non-opioid Pain Med Market Size YoY Growth 2018-2034
7.2 EMEA Non-opioid Pain Med Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Non-opioid Pain Med Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Non-opioid Pain Med Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Non-opioid Pain Med Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Non-opioid Pain Med Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Non-opioid Pain Med Market Size YoY Growth 2018-2034
8.2 China Non-opioid Pain Med Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Non-opioid Pain Med Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Non-opioid Pain Med Market Size YoY Growth 2018-2034
9.2 APAC Non-opioid Pain Med Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Non-opioid Pain Med Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Non-opioid Pain Med Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Non-opioid Pain Med Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Non-opioid Pain Med Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 WEX Pharmaceuticals Inc.
10.1.1 WEX Pharmaceuticals Inc. Company Information
10.1.2 WEX Pharmaceuticals Inc. Description and Business Overview
10.1.3 WEX Pharmaceuticals Inc. Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.1.4 WEX Pharmaceuticals Inc. Non-opioid Pain Med Products Offered
10.1.5 WEX Pharmaceuticals Inc. Recent Development
10.2 BASF
10.2.1 BASF Company Information
10.2.2 BASF Description and Business Overview
10.2.3 BASF Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.2.4 BASF Non-opioid Pain Med Products Offered
10.2.5 BASF Recent Development
10.3 Xinhua Pharm
10.3.1 Xinhua Pharm Company Information
10.3.2 Xinhua Pharm Description and Business Overview
10.3.3 Xinhua Pharm Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Xinhua Pharm Non-opioid Pain Med Products Offered
10.3.5 Xinhua Pharm Recent Development
10.4 Johnson & Johnson（McNeil Consumer Healthcare）
10.4.1 Johnson & Johnson（McNeil Consumer Healthcare） Company Information
10.4.2 Johnson & Johnson（McNeil Consumer Healthcare） Description and Business Overview
10.4.3 Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Products Offered
10.4.5 Johnson & Johnson（McNeil Consumer Healthcare） Recent Development
10.5 Granules Biocause
10.5.1 Granules Biocause Company Information
10.5.2 Granules Biocause Description and Business Overview
10.5.3 Granules Biocause Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Granules Biocause Non-opioid Pain Med Products Offered
10.5.5 Granules Biocause Recent Development
10.6 Novacyl
10.6.1 Novacyl Company Information
10.6.2 Novacyl Description and Business Overview
10.6.3 Novacyl Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novacyl Non-opioid Pain Med Products Offered
10.6.5 Novacyl Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Description and Business Overview
10.7.3 Pfizer Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Pfizer Non-opioid Pain Med Products Offered
10.7.5 Pfizer Recent Development
10.8 Hisoar
10.8.1 Hisoar Company Information
10.8.2 Hisoar Description and Business Overview
10.8.3 Hisoar Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hisoar Non-opioid Pain Med Products Offered
10.8.5 Hisoar Recent Development
10.9 Anant Pharmaceuticals Pvt. Ltd.
10.9.1 Anant Pharmaceuticals Pvt. Ltd. Company Information
10.9.2 Anant Pharmaceuticals Pvt. Ltd. Description and Business Overview
10.9.3 Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Products Offered
10.9.5 Anant Pharmaceuticals Pvt. Ltd. Recent Development
10.10 Strides Shasun
10.10.1 Strides Shasun Company Information
10.10.2 Strides Shasun Description and Business Overview
10.10.3 Strides Shasun Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Strides Shasun Non-opioid Pain Med Products Offered
10.10.5 Strides Shasun Recent Development
10.11 SI Group
10.11.1 SI Group Company Information
10.11.2 SI Group Description and Business Overview
10.11.3 SI Group Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.11.4 SI Group Non-opioid Pain Med Products Offered
10.11.5 SI Group Recent Development
10.12 Elam Pharma
10.12.1 Elam Pharma Company Information
10.12.2 Elam Pharma Description and Business Overview
10.12.3 Elam Pharma Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Elam Pharma Non-opioid Pain Med Products Offered
10.12.5 Elam Pharma Recent Development
10.13 AdvaCare Pharma
10.13.1 AdvaCare Pharma Company Information
10.13.2 AdvaCare Pharma Description and Business Overview
10.13.3 AdvaCare Pharma Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.13.4 AdvaCare Pharma Non-opioid Pain Med Products Offered
10.13.5 AdvaCare Pharma Recent Development
10.14 IOL
10.14.1 IOL Company Information
10.14.2 IOL Description and Business Overview
10.14.3 IOL Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.14.4 IOL Non-opioid Pain Med Products Offered
10.14.5 IOL Recent Development
10.15 Jingye Group
10.15.1 Jingye Group Company Information
10.15.2 Jingye Group Description and Business Overview
10.15.3 Jingye Group Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Jingye Group Non-opioid Pain Med Products Offered
10.15.5 Jingye Group Recent Development
10.16 NS Chemicals
10.16.1 NS Chemicals Company Information
10.16.2 NS Chemicals Description and Business Overview
10.16.3 NS Chemicals Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.16.4 NS Chemicals Non-opioid Pain Med Products Offered
10.16.5 NS Chemicals Recent Development
10.17 Hunan Zhongnan Pharmaceutical
10.17.1 Hunan Zhongnan Pharmaceutical Company Information
10.17.2 Hunan Zhongnan Pharmaceutical Description and Business Overview
10.17.3 Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Products Offered
10.17.5 Hunan Zhongnan Pharmaceutical Recent Development
10.18 Nanjing Pharmaceutical Factory
10.18.1 Nanjing Pharmaceutical Factory Company Information
10.18.2 Nanjing Pharmaceutical Factory Description and Business Overview
10.18.3 Nanjing Pharmaceutical Factory Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Nanjing Pharmaceutical Factory Non-opioid Pain Med Products Offered
10.18.5 Nanjing Pharmaceutical Factory Recent Development
10.19 Huayin Jinqiancheng Pharmaceutical Co., Ltd.
10.19.1 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Company Information
10.19.2 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Description and Business Overview
10.19.3 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Products Offered
10.19.5 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Recent Development
10.20 Mallinckrodt Pharmaceuticals
10.20.1 Mallinckrodt Pharmaceuticals Company Information
10.20.2 Mallinckrodt Pharmaceuticals Description and Business Overview
10.20.3 Mallinckrodt Pharmaceuticals Non-opioid Pain Med Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Mallinckrodt Pharmaceuticals Non-opioid Pain Med Products Offered
10.20.5 Mallinckrodt Pharmaceuticals Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Non-opioid Pain Med Industry Chain Analysis
11.2 Non-opioid Pain Med Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Non-opioid Pain Med Production Mode & Process
11.4 Non-opioid Pain Med Sales and Marketing
11.4.1 Non-opioid Pain Med Sales Channels
11.4.2 Non-opioid Pain Med Distributors
11.5 Non-opioid Pain Med Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Non-opioid Pain Med CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Non-opioid Pain Med Market Trends
Table 3. Non-opioid Pain Med Market Drivers
Table 4. Non-opioid Pain Med Market Challenges
Table 5. Non-opioid Pain Med Market Restraints
Table 6. Global Non-opioid Pain Med Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Non-opioid Pain Med Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Non-opioid Pain Med Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Non-opioid Pain Med Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Non-opioid Pain Med, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Non-opioid Pain Med Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Non-opioid Pain Med Revenue Share by Manufacturer, 2018-2023
Table 13. Global Non-opioid Pain Med Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Non-opioid Pain Med Sales Share by Manufacturer, 2018-2023
Table 15. Global Non-opioid Pain Med Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Non-opioid Pain Med Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Non-opioid Pain Med by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Pain Med as of 2024)
Table 18. Global Key Manufacturers of Non-opioid Pain Med, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Non-opioid Pain Med, Product Offered and Application
Table 20. Global Key Manufacturers of Non-opioid Pain Med, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Non-opioid Pain Med in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Non-opioid Pain Med Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Non-opioid Pain Med Revenue Share by Players, (2018-2023)
Table 25. United States Non-opioid Pain Med Sales by Players, (K Units), (2018-2023)
Table 26. United States Non-opioid Pain Med Sales Share by Players, (2018-2023)
Table 27. Global Non-opioid Pain Med Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Non-opioid Pain Med Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Non-opioid Pain Med Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Non-opioid Pain Med Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Non-opioid Pain Med Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Non-opioid Pain Med Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Non-opioid Pain Med Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Non-opioid Pain Med Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Non-opioid Pain Med Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Non-opioid Pain Med Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Non-opioid Pain Med Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Non-opioid Pain Med Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Non-opioid Pain Med Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Non-opioid Pain Med Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Non-opioid Pain Med Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Non-opioid Pain Med Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Non-opioid Pain Med Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Non-opioid Pain Med Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Non-opioid Pain Med Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Non-opioid Pain Med Sales in Volume by Country (2024-2034) & (K Units)
Table 47. WEX Pharmaceuticals Inc. Company Information
Table 48. WEX Pharmaceuticals Inc. Description and Business Overview
Table 49. WEX Pharmaceuticals Inc. Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. WEX Pharmaceuticals Inc. Non-opioid Pain Med Product
Table 51. WEX Pharmaceuticals Inc. Recent Development
Table 52. BASF Company Information
Table 53. BASF Description and Business Overview
Table 54. BASF Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. BASF Non-opioid Pain Med Product
Table 56. BASF Recent Development
Table 57. Xinhua Pharm Company Information
Table 58. Xinhua Pharm Description and Business Overview
Table 59. Xinhua Pharm Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Xinhua Pharm Non-opioid Pain Med Product
Table 61. Xinhua Pharm Recent Development
Table 62. Johnson & Johnson（McNeil Consumer Healthcare） Company Information
Table 63. Johnson & Johnson（McNeil Consumer Healthcare） Description and Business Overview
Table 64. Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Product
Table 66. Johnson & Johnson（McNeil Consumer Healthcare） Recent Development
Table 67. Granules Biocause Company Information
Table 68. Granules Biocause Description and Business Overview
Table 69. Granules Biocause Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Granules Biocause Non-opioid Pain Med Product
Table 71. Granules Biocause Recent Development
Table 72. Novacyl Company Information
Table 73. Novacyl Description and Business Overview
Table 74. Novacyl Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Novacyl Non-opioid Pain Med Product
Table 76. Novacyl Recent Development
Table 77. Pfizer Company Information
Table 78. Pfizer Description and Business Overview
Table 79. Pfizer Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Pfizer Non-opioid Pain Med Product
Table 81. Pfizer Recent Development
Table 82. Hisoar Company Information
Table 83. Hisoar Description and Business Overview
Table 84. Hisoar Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Hisoar Non-opioid Pain Med Product
Table 86. Hisoar Recent Development
Table 87. Anant Pharmaceuticals Pvt. Ltd. Company Information
Table 88. Anant Pharmaceuticals Pvt. Ltd. Description and Business Overview
Table 89. Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Product
Table 91. Anant Pharmaceuticals Pvt. Ltd. Recent Development
Table 92. Strides Shasun Company Information
Table 93. Strides Shasun Description and Business Overview
Table 94. Strides Shasun Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Strides Shasun Non-opioid Pain Med Product
Table 96. Strides Shasun Recent Development
Table 97. SI Group Company Information
Table 98. SI Group Description and Business Overview
Table 99. SI Group Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. SI Group Non-opioid Pain Med Product
Table 101. SI Group Recent Development
Table 102. Elam Pharma Company Information
Table 103. Elam Pharma Description and Business Overview
Table 104. Elam Pharma Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Elam Pharma Non-opioid Pain Med Product
Table 106. Elam Pharma Recent Development
Table 107. AdvaCare Pharma Company Information
Table 108. AdvaCare Pharma Description and Business Overview
Table 109. AdvaCare Pharma Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. AdvaCare Pharma Non-opioid Pain Med Product
Table 111. AdvaCare Pharma Recent Development
Table 112. IOL Company Information
Table 113. IOL Description and Business Overview
Table 114. IOL Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. IOL Non-opioid Pain Med Product
Table 116. IOL Recent Development
Table 117. Jingye Group Company Information
Table 118. Jingye Group Description and Business Overview
Table 119. Jingye Group Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Jingye Group Non-opioid Pain Med Product
Table 121. Jingye Group Recent Development
Table 122. NS Chemicals Company Information
Table 123. NS Chemicals Description and Business Overview
Table 124. NS Chemicals Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. NS Chemicals Non-opioid Pain Med Product
Table 126. NS Chemicals Recent Development
Table 127. Hunan Zhongnan Pharmaceutical Company Information
Table 128. Hunan Zhongnan Pharmaceutical Description and Business Overview
Table 129. Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Product
Table 131. Hunan Zhongnan Pharmaceutical Recent Development
Table 132. Nanjing Pharmaceutical Factory Company Information
Table 133. Nanjing Pharmaceutical Factory Description and Business Overview
Table 134. Nanjing Pharmaceutical Factory Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Nanjing Pharmaceutical Factory Non-opioid Pain Med Product
Table 136. Nanjing Pharmaceutical Factory Recent Development
Table 137. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Company Information
Table 138. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Description and Business Overview
Table 139. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Product
Table 141. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Recent Development
Table 142. Mallinckrodt Pharmaceuticals Company Information
Table 143. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 144. Mallinckrodt Pharmaceuticals Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Mallinckrodt Pharmaceuticals Non-opioid Pain Med Product
Table 146. Mallinckrodt Pharmaceuticals Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Non-opioid Pain Med Customers List
Table 150. Non-opioid Pain Med Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-opioid Pain Med Product Picture
Figure 2. Global Non-opioid Pain Med Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Non-opioid Pain Med Market Size 2018-2034 (US$ Million)
Figure 4. Global Non-opioid Pain Med Sales 2018-2034 (K Units)
Figure 5. United States Non-opioid Pain Med Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Non-opioid Pain Med Market Size 2018-2034 (US$ Million)
Figure 7. United States Non-opioid Pain Med Sales 2018-2034 (K Units)
Figure 8. United States Non-opioid Pain Med Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Non-opioid Pain Med Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Non-opioid Pain Med Report Years Considered
Figure 11. Product Picture of Diclofenac Sodium
Figure 12. Product Picture of Acetaminophen
Figure 13. Product Picture of Indomethacin
Figure 14. Product Picture of Ibuprofen
Figure 15. Product Picture of Aspirin
Figure 16. Product Picture of Others
Figure 17. Global Non-opioid Pain Med Market Share by Type in 2024 & 2034
Figure 18. Global Non-opioid Pain Med Sales in Value by Type (2018-2034) & (US$ Million)
Figure 19. Global Non-opioid Pain Med Sales Market Share in Value by Type (2018-2034)
Figure 20. Global Non-opioid Pain Med Sales by Type (2018-2034) & (K Units)
Figure 21. Global Non-opioid Pain Med Sales Market Share in Volume by Type (2018-2034)
Figure 22. Global Non-opioid Pain Med Price by Type (2018-2034) & (US$/Unit)
Figure 23. United States Non-opioid Pain Med Market Share by Type in 2024 & 2034
Figure 24. United States Non-opioid Pain Med Sales in Value by Type (2018-2034) & (US$ Million)
Figure 25. United States Non-opioid Pain Med Sales Market Share in Value by Type (2018-2034)
Figure 26. United States Non-opioid Pain Med Sales by Type (2018-2034) & (K Units)
Figure 27. United States Non-opioid Pain Med Sales Market Share in Volume by Type (2018-2034)
Figure 28. United States Non-opioid Pain Med Price by Type (2018-2034) & (US$/Unit)
Figure 29. Product Picture of Mild Pain
Figure 30. Product Picture of Moderate Pain
Figure 31. Global Non-opioid Pain Med Market Share by Application in 2024 & 2034
Figure 32. Global Non-opioid Pain Med Sales in Value by Application (2018-2034) & (US$ Million)
Figure 33. Global Non-opioid Pain Med Sales Market Share in Value by Application (2018-2034)
Figure 34. Global Non-opioid Pain Med Sales by Application (2018-2034) & (K Units)
Figure 35. Global Non-opioid Pain Med Sales Market Share in Volume by Application (2018-2034)
Figure 36. Global Non-opioid Pain Med Price by Application (2018-2034) & (US$/Unit)
Figure 37. United States Non-opioid Pain Med Market Share by Application in 2024 & 2034
Figure 38. United States Non-opioid Pain Med Sales in Value by Application (2018-2034) & (US$ Million)
Figure 39. United States Non-opioid Pain Med Sales Market Share in Value by Application (2018-2034)
Figure 40. United States Non-opioid Pain Med Sales by Application (2018-2034) & (K Units)
Figure 41. United States Non-opioid Pain Med Sales Market Share in Volume by Application (2018-2034)
Figure 42. United States Non-opioid Pain Med Price by Application (2018-2034) & (US$/Unit)
Figure 43. Americas Non-opioid Pain Med Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 44. Americas Non-opioid Pain Med Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 45. Americas Non-opioid Pain Med Sales by Type (2018-2034) & (K Units)
Figure 46. Americas Non-opioid Pain Med Sales Market Share in Volume by Type (2018-2034)
Figure 47. Americas Non-opioid Pain Med Sales by Application (2018-2034) & (K Units)
Figure 48. Americas Non-opioid Pain Med Sales Market Share in Volume by Application (2018-2034)
Figure 49. United States Non-opioid Pain Med Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Canada Non-opioid Pain Med Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Mexico Non-opioid Pain Med Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. Brazil Non-opioid Pain Med Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 53. EMEA Non-opioid Pain Med Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 54. EMEA Non-opioid Pain Med Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 55. EMEA Non-opioid Pain Med Sales by Type (2018-2034) & (K Units)
Figure 56. EMEA Non-opioid Pain Med Sales Market Share in Volume by Type (2018-2034)
Figure 57. EMEA Non-opioid Pain Med Sales by Application (2018-2034) & (K Units)
Figure 58. EMEA Non-opioid Pain Med Sales Market Share in Volume by Application (2018-2034)
Figure 59. Europe Non-opioid Pain Med Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. Middle East Non-opioid Pain Med Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. Africa Non-opioid Pain Med Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 62. China Non-opioid Pain Med Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 63. China Non-opioid Pain Med Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 64. China Non-opioid Pain Med Sales by Type (2018-2034) & (K Units)
Figure 65. China Non-opioid Pain Med Sales Market Share in Volume by Type (2018-2034)
Figure 66. China Non-opioid Pain Med Sales by Application (2018-2034) & (K Units)
Figure 67. China Non-opioid Pain Med Sales Market Share in Volume by Application (2018-2034)
Figure 68. APAC Non-opioid Pain Med Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 69. APAC Non-opioid Pain Med Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 70. APAC Non-opioid Pain Med Sales by Type (2018-2034) & (K Units)
Figure 71. APAC Non-opioid Pain Med Sales Market Share in Volume by Type (2018-2034)
Figure 72. APAC Non-opioid Pain Med Sales by Application (2018-2034) & (K Units)
Figure 73. APAC Non-opioid Pain Med Sales Market Share in Volume by Application (2018-2034)
Figure 74. Japan Non-opioid Pain Med Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. South Korea Non-opioid Pain Med Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. China Taiwan Non-opioid Pain Med Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Non-opioid Pain Med Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. India Non-opioid Pain Med Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 79. Non-opioid Pain Med Value Chain
Figure 80. Non-opioid Pain Med Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed